Synthetic Cartilage Implants for Joint Pain
Summary
Synthetic cartilage implants are considered investigational for the treatment of articular cartilage damage. The Cartiva synthetic polyvinyl alcohol implant was FDA-approved in 2016 for painful degenerative or posttraumatic arthritis in the first metatarsophalangeal joint, and the policy states that the Federal Employee Program may dictate that FDA-approved devices are not considered investigational and may be assessed only on the basis of medical necessity. The 09/11/2025 review made no changes to the policy statement.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.